1-[2-chloro-4-(pentyloxy)benzyl]-2-methyl-1H-benzimidazole-6-carboxylic acid

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并咪唑类
• 英文名称: 1-[2-chloro-4-(pentyloxy)benzyl]-2-methyl-1H-benzimidazole-6-carboxylic acid
• 英文别名: 3-[(2-chloro-4-pentoxyphenyl)methyl]-2-methylbenzimidazole-5-carboxylic acid
• 化学式: C₂₁H₂₃ClN₂O₃
• 分子量: 386.878
• InChiKey: YRKAOFXFZRQFIX-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  5.4
• 重原子数：
  27
• 可旋转键数：
  8
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  64.4
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  1-[2-chloro-4-(pentyloxy)benzyl]-2-methyl-1H-benzimidazole-6-carboxylic acid 、 2-氯乙酰乙酸乙酯 在 sodium hydride 作用下， 以 DMF (N,N-dimethyl-formamide) 为溶剂， 反应 4.5h， 生成 1-(ethoxycarbonyl)-2-oxopropyl 1-[2-chloro-4-(pentyloxy)benzyl]-2-methyl-1H-benzimidazole-6-carboxylate
  参考文献：
  名称：

  [EN] BENZIMIDAZOLE COMPOUNDS HAVING HYPOGLYCEMIC ACTIVITY
  [FR] COMPOSES DE BENZIMIDAZOLE

  摘要：

  公开号：

  WO2004108686A3

文献信息

• Benzimidazole compounds
  申请人：Hayashida Hisashi

  公开号：US20050014812A1

  公开（公告）日：2005-01-20

  The present invention provides novel benzimidazole compounds of the formula (I): wherein each symbol is as defined in the specification, salts thereof and prodrugs thereof, which are useful in treating, for example, the diseases curable through decrease in blood sugar level.

  本发明提供了一种新的苯并咪唑化合物，其化学式为(I)：其中每个符号如规范中所定义，其盐和前药，可用于治疗例如通过降低血糖水平可治愈的疾病。
• BENZIMIDAZOLE DERIVATIVES
  申请人：FUJISAWA PHARMACEUTICAL CO., LTD.

  公开号：EP1142880A1

  公开（公告）日：2001-10-10

  The present invention provides novel benzimidazole derivatives of the following formula (I) and salts thereof: wherein R1 represents a lower alkyl group or a lower alkyloxy-lower alkyl group: R2 represents a hydrogen atom, a halogen atom, an alkyl group having 1 to 8 carbon atoms, an aryl group, and such; R3 represents a lower alkyl group, a lower alkenyl group, an aryl group, a lower alkylaryl group, an aryl-lower alkenyl group, a halothienyl group, a lower alkylamino group, or an aryl-lower alkylamino group; A represents a benzene ring, a naphthalene ring, or a pyridine ring; and X represents a halogen atom. The derivatives and their salts have blood sugar level-depressing activity or PDE5-inhibiting activity, and are useful as pharmaceutical preparations.

  本发明提供了下式(I)的新型苯并咪唑衍生物及其盐类： 其中 R1 代表低级烷基或低级烷氧基-低级烷基：R2代表氢原子、卤素原子、具有1至8个碳原子的烷基、芳基等；R3代表低级烷基、低级烯基、芳基、低级烷芳基、芳基-低级烯基、卤代噻吩基、低级烷氨基或芳基-低级烷氨基；A代表苯环、萘环或吡啶环；X代表卤素原子。这些衍生物及其盐类具有降低血糖水平的活性或 PDE5 抑制活性，可用作药物制剂。
• US6869950B1
  申请人：——

  公开号：US6869950B1

  公开（公告）日：2005-03-22
• [EN] BENZIMIDAZOLE COMPOUNDS<br/>[FR] COMPOSES DE BENZIMIDAZOLE
  申请人：FUJISAWA PHARMACEUTICAL CO

  公开号：WO2004108686A2

  公开（公告）日：2004-12-16

  The present invention provides novel benzimidazole compounds of the formula (I): wherein each symbol is as defined in the specification, salts thereof and prodrugs thereof, which are useful in treating, for example, the diseases curable through decrease in blood sugar level.
• [EN] BENZIMIDAZOLE COMPOUNDS HAVING HYPOGLYCEMIC ACTIVITY<br/>[FR] COMPOSES DE BENZIMIDAZOLE
  申请人：FUJISAWA PHARMACEUTICAL CO

  公开号：WO2004108686A3

  公开（公告）日：2005-05-26